International Journal of Tumor Therapy

International Journal of Tumor Therapy is an international journal publishing original research aticles, critical reviews, research notes, debate and short reports in all areas of tumor therapy. The journal aims to provide a forum for doctors and academicians all over the world to promote, share, and discuss various new issues and developments in tumor therapy related problems.

Ayman Noreddin

Editorial Board Member of International Journal of Tumor Therapy

Head of Academic Department/Faculty, Hampton Univeristy, USA

Research Areas

PK/PD of Anti-infectives and Anti-neoplastics

Education

Ph.DPharmaceutical Sciences (Clinical Pharmacy), School of Pharmacy, University of the Pacific
M.ScPharmaceutical Sciences (Biochemistry), Faculty of Pharmacy, Cairo University
BS PharmacyFaculty of Pharmacy, Cairo University

Publications: Conferences/Workshops/Symposiums/Journals/Books

[1]   Zhanel GG, Rossnagel E, Nichol K, Cox L, Karlowsky JA, Zelenitsky S, Noreddin AM, Hoban DJ. Ceftaroline pharmacodynamic activity versus community-associated and healthcare-associated methicillin-resistant Staphylococcus aureus, heteroresistant vancomycin-intermediate S. aureus, vancomycin-intermediate S. aureus and vancomycin-resistant S. aureus using an in vitro model. J Antimicrob Chemother. 2011 Mar 23.
[2]  Ayman M. Noreddin and Walid F. ElKhatib Antibacterial Therapy in the Elderly. In: Frontiers in Anti-Infective Drug Discovery, Bentham Science Publishers Ltd, 2010
[3]  Salem AH, Elkhatib WF, and Noreddin AM. Pharmacodynamic assessment of vancomycin–rifampicin combination against methicillin resistant Staphylococcus aureus biofilm: a parametric response surface analysis. Journal of Pharmacy and Pharmacology. 63:73-79, 2010.
[4]  Salem AH, Elkhatib WF, Ahmed GF, Noreddin AM. Noreddin AM and Elkhatib WF. Levofloxacin in the Treatment of Community Acquired Pneumonia. Expert Review of Anti-Infective Therapy. Pharmacodynamics of moxifloxacin versus vancomycin against biofilms of methicillin-resistant Staphylococcus aureus and epidermidis in an in vitro model.J Chemother.22(4):238-42, 2010. Expert Rev Anti Infect Ther
[5]  Galal AM, Gul W, Noreddin AM, Slade D. An Update on the synthesis and antibacterial effects of Carbapenems. Recent Pat Anti-infect Drug Discov. 2009 Nov 23. [Epub ahead of print].
[6]  Noreddin AM and El-Khatib WF. Novel in vitro pharmacodynamic model simulating ofloxacin pharmacokinetics in the treatment of Pseudomonas aeruginosa biofilm-associated infections. Journal of Infection and Public Health.2:120-128, 2009.
[7]  El-Khatib WF and Noreddin AM. A new fluorogenic assay for monitoring and determining planktonic and biofilm forms of Pseudomonas aeruginosa viable count in vitro. Journal of Rapid Methods and Automation in Microbiology. 17:304-314, 2009.
[8]  Zhanel GG, Voth D, Nichol K, Karlowsky JA, Noreddin AM, Hoban DJ. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model. J Antimicrob Chemother.64(2):364-9, 2009.
[9]  Noreddin AM, El-Khatib WF, Aolie, J, Salem AH and Zanel GG. Pharmacodynamic Target Attainment Potential of Azithromycin, Clarithromycin and Telithromycin in Serum and Epithelial Lining Fluid (ELF) of Community Acquired Pneumonia (CAP) Patients with Penicillin-Susceptible, Intermediate and Resistant Streptococcus pneumoniae. International Journal of Infectious Diseases.13(4):483-7.2009.
[10]  El-Khatib WF, Haynes VL and Noreddin AM. Microbiological appraisal of levofloxacin activity against Pseudomonas aeruginosa biofilm in combination with different calcium channel blockers.Journal of Chemotherapy. 21(2): 37-45, 2009.
[11]  El-Khatib WF, Haynes VL and Noreddin AM. Unexpected induction of resistant Pseudomonas aeruginosa biofilm to fluoroquinolone by diltiazem: A new perspective of microbiological drug-drug interaction. Journal of Infection and Public Health.1(2): 105-112, 2009.
[12]  Noreddin AM. Haynes, V and El-Khatib, WF. Antimicrobial therapy in the elderly. Advances in Infectious Diseasess; 2010.
[13]  Zhanel GG and Noreddin AM. Pharmacokinetics and pharmacodynamics of the new generation quinolones. In: Recent advances in antimicrobial agents and chemotherapy. Global Reviews; 2004.
[14]  Zhanel G and Noreddin A. Pharmacokinetics and pharmacodynamics (PK/PD) of fluoroquinolones: tools for combating bacteria and preventing resistance. In: The quinolones: an unfolding story. Birkhauser, Verlag AG, Basel, Switzerland; 2003. (Biosciences (Milestones in Drug Therapy).